Novartis Looks To Biotech Sector

Swiss drugmaker Novartis may invest in Malaysia's biotechnology industry, after CEO Daniel Vasella reportedly expressed interest during a meeting with the country's Minister for Science, Technology and Innovations. Novartis is said to be evaluating Malaysia's rich biodiversity with the aim of producing novel treatments.

To read the full article, please choose one of the following options: